Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 11.91% vs -27.18% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -138.36% vs -33.11% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -110.44% vs -49.36% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 14.42% vs -16.84% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Orchid Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 11.91% vs -27.18% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -13.10% vs 12.04% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -138.36% vs -33.11% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -121.00% vs 37.58% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -110.44% vs -49.36% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -104.88% vs 30.10% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 14.42% vs -16.84% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.01% vs -12.37% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






